Loading clinical trials...

Telepalliation - Digital Platform for Patients in Palliation and Their Relatives | Clinical Trials | Clareo Health

UNKNOWNNA

Telepalliation - Digital Platform for Patients in Palliation and Their Relatives

Elepalliation - Digital Platform for Patienter i Palliation og Deres pårørende

NCT04995848•Aalborg University

View on ClinicalTrials.gov

Summary

This project has focus on patients in palliation testing a digital platform TelePal.dk.

Detailed Description

The aim of the RCT study is to: • Test, implement, and evaluate a telepalliation program for patients receiving palliative care (cancer, heart failure (HF), COPD, and motor neuron disease) from a clinical, psychosocial, inter-organizational, and health economic perspective.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Over 18 years
•Live in Esbjerg, Varde, Billund, Fanø or Vejen Municipality
•Cancer, heart failure, chronic obstructive pulmonary disease (COPD), and motor neuron disease (neurological diseases) referred to the Palliation Team at Southwest Jutland Hospital
•Basic computer skills or a relative who has basic computer skills

Exclusion Criteria

•Delirium at enrolment based on CAM score
•Active psychiatric history (as noted in the medical record) other than depression or anxiety related to the main diagnosis referred to palliative care
•Lack of ability to cooperate

Locations (1)

Palliative Team, South West Jutland Hospital

Esbjerg, Denmark

Key Dates

Start Date

May 26, 2021

Primary Completion Date

August 1, 2024

Completion Date

August 1, 2024

Last Updated

July 19, 2023

Enrollment

182

ESTIMATED participants

Conditions

CancerHeart FailureChronic Obstructive Pulmonary DiseaseNeurological Diseases

Interventions

Telepalliation

OTHER

Contacts

Birthe Dinesen, MSc, PhD

CONTACT

+4520515944 bid@hst.aau.dk

Jarl Voss Andersen Sigaard, MD

CONTACT

Jarl.Sigaard@rsyd.dk

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

NCT05884320

GlandSalivary Gland Cancers

View study

RECRUITINGPHASE1

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

NCT06696768

Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 19, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Telepalliation - Digital Platform for Patients in Palliation and Their Relatives

Inclusion Criteria

Exclusion Criteria

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer